Devroe Eric
Chief Operating Officer · 6 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Award | 72,981 | $0.00 | $0.00 | filing |
| 2026-05-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 613 | $1.92 | $1,176.96 | filing |
| 2026-02-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 723 | $1.63 | $1,178.49 | filing |
| 2026-01-13 | ACRV | Acrivon Therapeutics, Inc. | Buy | 10,000 | $1.72 | $17,218.00 | filing |
| 2025-11-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 613 | $2.24 | $1,373.12 | filing |
| 2025-08-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 613 | $1.39 | $852.07 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.